Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Shedding light on tapeworms

24.06.2015

Professor Klaus Brehm from Würzburg is granted 750,000 euros for a new research project on tapeworms. His work may bring advances in fighting worm infections, but also in wholly different areas of medicine.

Parasitic worms are a major problem worldwide, especially in developing countries. In tropical regions, for example, several million people are suffering from schistosomiasis. In the course of this infectious disease, worms damage the liver and other organs. They can even cause cancer.


Head of a fox tapeworm: The parasite attaches to the intestinal mucosa of its host by hooks and suckers. Special "kidney cells" that help to drain the head are dyed in green.

(Image: Uriel Koziol)

Millions of people are infected with tapeworms. Particularly dangerous: dog and fox tapeworms. Their larvae form cysts in the tissue of the lung, liver or brain. These cysts proliferate or grow in the body much like tumours to reach a considerable size in some cases. In some species this can cause complications such as blindness and epilepsy, with others it may lead to death.

There have been no vaccines against these pathogens so far and only a very limited repertoire of drugs. Tapeworm cysts, for example, can only be kept in check with a lifelong chemotherapy. Once treatment is stopped, they will simply continue to grow. In Germany, around 50 people are infected with the fox tapeworm each year. This seems little compared to the figures worldwide, however, this is hardly a comfort to those affected.

Wellcome Trust funds research consortium

An international research consortium now wants to find new strategies to combat schistosomiasis and tapeworms. The Wellcome Trust, the UK's largest private funder of biomedical and veterinary research, supports the project: It promotes the "Flatworm Functional Genomics Initiative" with a Strategic Award worth five million euros. The project is set to start in late 2015 to run for five years.

Around 750,000 euros of the grant will be allocated to the team of Professor Klaus Brehm, a tapeworm expert, at the Institute of Hygiene and Microbiology of the University of Würzburg. The money is highly welcome, because: "We are far behind in our knowledge of worm parasites in infection research," as Brehm puts it. He attributes this to the fact that the tapeworm genome was only recently mapped. Moreover, there are no methods available to analyse the worms' genetic functions in the lab. But this would be necessary to find potential targets for drugs or vaccines.

Investigating the worms' genetic functions

After all: The DNA of four tapeworm species was mapped in 2013. Brehm was involved in this work which was equally funded by the Wellcome Trust and was published in the journal "Nature". "Now we have to develop methods to manipulate the worms' genes, because you have to be able to knock out a gene to understand its function."

Brehm designates the venture as a "high-risk project", meaning that it is so ambitious that the scientists could come out without a result after the project term. "But if we are successful, we will considerably advance the research in this field," the Würzburg professor adds.

Perfectly camouflaged to hide from the immune system

The scientists are not only interested in new drugs and vaccines. They see another potential benefit in the tapeworm cysts: These dangerous structures are attached to the human body like perfectly transplanted organs; they cannot be harmed by the immune system.

"How do the worms manage to camouflage themselves so efficiently? Finding the answer to that question could mean progress for organ transplantation," Brehm says. It is conceivable, for example, to disguise transplanted organs accordingly to protect them against the immune system's attack. The treatment of allergies and autoimmune diseases, too, could benefit from a better understanding of the strategies used by the worms to keep the immune system at bay.

The names of the project partners

The FUGI project (Flatworm Functional Genomics Initiative) is led by Professor Karl Hoffmann of the Aberysthwyth University in the UK.

Other partners are Matthew Berriman (Wellcome Trust Sanger Institute, UK), Ludovic Vallier (Cambridge University, UK), Professor Christoph Grunau (University of Perpignan and Centre National de la Recherche Scientifique, France), Professor Klaus Brehm (University of Würzburg, Germany), James Collins (University of Texas Southwestern Medical Center, USA), and Professor Paul Brindley (George Washington University, USA).

Nature publication on the tapeworm genome

“The genomes of four tapeworm species reveal adaptations to parasitism”, Nature 496, 57-63, 4. April 2013, DOI: 10.1038/nature12031

Contact

Prof. Dr. Klaus Brehm, Institut für Hygiene und Mikrobiologie, Universität Würzburg, phone +49 931 31-46168, kbrehm@hygiene.uni-wuerzburg.de

Robert Emmerich | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Fingerprint' technique spots frog populations at risk from pollution
27.03.2017 | Lancaster University

nachricht Parallel computation provides deeper insight into brain function
27.03.2017 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Northern oceans pumped CO2 into the atmosphere

27.03.2017 | Earth Sciences

Fingerprint' technique spots frog populations at risk from pollution

27.03.2017 | Life Sciences

Big data approach to predict protein structure

27.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>